Literature DB >> 16936702

Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia.

Samuel A McLean1, David A Williams, Phyllis K Stein, Richard E Harris, Angela K Lyden, Gail Whalen, Karen M Park, Israel Liberzon, Ananda Sen, Richard H Gracely, James N Baraniuk, Daniel J Clauw.   

Abstract

Previous studies have identified stress system dysregulation in fibromyalgia (FM) patients; such dysregulation may be involved in the generation and/or maintenance of pain and other symptoms. Corticotropin-releasing factor (CRF) is the principal known central nervous system mediator of the stress response; however, to date no studies have examined cerebrospinal fluid (CSF) CRF levels in patients with FM. The relationship between CSF CRF level, heart rate variability (HRV), and pain, fatigue, and depressive symptoms was examined in patients with FM. Among participants (n=26), CSF CRF levels were associated with sensory pain symptoms (r=0.574, p=0.003) and affective pain symptoms (r=0.497, p=0.011), but not fatigue symptoms. Increased HRV was also strongly associated with increased CSF CRF and FM pain. In multivariate analyses adjusting for age, sex, and depressive symptoms, the association between CSF CRF and sensory pain symptoms (t=2.54, p=0.027) persisted. Women with FM who reported a history of physical or sexual abuse had lower CSF CRF levels than women who did not report such a history. CSF CRF levels are associated with both pain symptoms and variation in autonomic function in FM. Differences in CSF CRF levels among women with and without a self-reported history of physical or sexual abuse suggest that subgroups of FM patients may exist with different neurobiological characteristics. Further studies are needed to better understand the nature of the association between CSF CRF and pain symptoms in FM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936702      PMCID: PMC4831068          DOI: 10.1038/sj.npp.1301200

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  46 in total

Review 1.  Importance of studying the contributions of early adverse experience to neurobiological findings in depression.

Authors:  Christine Heim; Paul M Plotsky; Charles B Nemeroff
Journal:  Neuropsychopharmacology       Date:  2004-04       Impact factor: 7.853

Review 2.  Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms.

Authors:  D J Clauw; G P Chrousos
Journal:  Neuroimmunomodulation       Date:  1997 May-Jun       Impact factor: 2.492

3.  Assessing depression among persons with chronic pain using the Center for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: a comparative analysis.

Authors:  M E Geisser; R S Roth; M E Robinson
Journal:  Clin J Pain       Date:  1997-06       Impact factor: 3.442

4.  Labeling partner violence: when do victims differentiate among acts?

Authors:  S L Hamby; B Gray-Little
Journal:  Violence Vict       Date:  2000

Review 5.  Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.

Authors:  P W Gold; G P Chrousos
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

6.  Relationship between traumatic events in childhood and chronic pain.

Authors:  R T Goldberg; W N Pachas; D Keith
Journal:  Disabil Rehabil       Date:  1999-01       Impact factor: 3.033

7.  Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis.

Authors:  G A McCain; K S Tilbe
Journal:  J Rheumatol Suppl       Date:  1989-11

8.  Mechanisms underlying very-low-frequency RR-interval oscillations in humans.

Authors:  J A Taylor; D L Carr; C W Myers; D L Eckberg
Journal:  Circulation       Date:  1998-08-11       Impact factor: 29.690

9.  Diurnal variation of cerebrospinal fluid immunoreactive corticotropin-releasing hormone levels in healthy volunteers.

Authors:  M A Kling; M D DeBellis; D K O'Rourke; S J Listwak; T D Geracioti; I E McCutcheon; K T Kalogeras; E H Oldfield; P W Gold
Journal:  J Clin Endocrinol Metab       Date:  1994-07       Impact factor: 5.958

10.  Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome.

Authors:  E N Griep; J W Boersma; E R de Kloet
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

View more
  29 in total

Review 1.  Understanding fibromyalgia: lessons from the broader pain research community.

Authors:  David A Williams; Daniel J Clauw
Journal:  J Pain       Date:  2009-08       Impact factor: 5.820

2.  [Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].

Authors:  C Sommer; W Häuser; K Gerhold; P Joraschky; F Petzke; T Tölle; N Uçeyler; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

3.  mTOR and Erk1/2 Signaling in the Cerebrospinal Fluid-Contacting Nucleus is Involved in Neuropathic Pain.

Authors:  Guangling Li; Xianfu Lu; Suming Zhang; Qiangqiang Zhou; Licai Zhang
Journal:  Neurochem Res       Date:  2015-04-07       Impact factor: 3.996

Review 4.  Stress-induced pain: a target for the development of novel therapeutics.

Authors:  Anthony C Johnson; Beverley Greenwood-Van Meerveld
Journal:  J Pharmacol Exp Ther       Date:  2014-09-05       Impact factor: 4.030

Review 5.  [Fibromyalgia].

Authors:  M Späth
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

6.  The role of stress in rheumatic diseases.

Authors:  Afton L Hassett; Daniel J Clauw
Journal:  Arthritis Res Ther       Date:  2010-06-07       Impact factor: 5.156

7.  Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia.

Authors:  Alice A Larson; Myra G Nunez; Casey L Kissel; Katalin J Kovács
Journal:  Eur J Neurosci       Date:  2015-10-09       Impact factor: 3.386

Review 8.  Fibromyalgia syndrome in need of effective treatments.

Authors:  Theoharis C Theoharides; Irene Tsilioni; Lauren Arbetman; Smaro Panagiotidou; Julia M Stewart; Rae M Gleason; Irwin J Russell
Journal:  J Pharmacol Exp Ther       Date:  2015-08-25       Impact factor: 4.030

Review 9.  Neurobiology of fibromyalgia and chronic widespread pain.

Authors:  Kathleen A Sluka; Daniel J Clauw
Journal:  Neuroscience       Date:  2016-06-09       Impact factor: 3.590

Review 10.  From Hans Selye's discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases.

Authors:  Yvette Taché; Stefan Brunnhuber
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.